In Germany, the forecast for stomach malignant neoplasms mortality among women shows a slight annual decrease from 2024 to 2028, starting at 8.1 deaths per 100,000 women in 2024 and reaching 7.8 by 2028. This indicates a continual downtrend over the projected years with a compound annual growth rate (CAGR) reflecting a moderate annual decrease.
Future trends to watch include the potential impact of improved screening programs and advancements in treatment that could further drive down mortality rates. Additionally, public health initiatives promoting lifestyle changes may also play a crucial role in reducing these numbers. Continuous monitoring of these aspects is critical to understand the evolving dynamics of this health concern.
